Imunon announces new immunogenicity data from phase 1 clinical trial of its dna vaccine in treatment of covid-19

Results of imnn-101 proof-of-concept study demonstrate persistent immunogenicity in trial participants and further validate placcine ® technology

DNA Ratings Summary

DNA Quant Ranking